SG&A expenses in the third quarter of 2023 were $19.1 million, up 28%, versus $14.9 million in the year-ago quarter, reflecting SOX implementation and consulting costs and increased expenses in sales and clinical personnel costs and travel.

Nov 9, 2023 / CFO / receipt, needs a key / Shelley Tunant, CFO | earnings call 2023-11-09 | transcript f6187686-662b-44f2-8c18-6ecbf7d711b4 | chars 9235-9475 | segment 9